BioMed Research International

BioMed Research International / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 4302726 | 10 pages | https://doi.org/10.1155/2018/4302726

Harmful Roles of TLR3 and TLR9 in Cardiac Dysfunction Developing during Polymicrobial Sepsis

Academic Editor: Shin-ichi Yokota
Received06 Mar 2018
Revised21 Aug 2018
Accepted30 Aug 2018
Published30 Sep 2018

Abstract

We determined the roles of TLR3 and TLR9 in adverse events of polymicrobial sepsis, with a focus on development of septic cardiomyopathy, progression of which we have recently shown to be complement- and histones-dependent. So Wt, TLR3-knocked out (K.O.), and TLR9-K.O. mice were subjected to polymicrobial sepsis following cecal ligation and puncture (CLP). In the absence of either TLR3 or TLR9, the intensity of echocardiogram (Echo)-Doppler dysfunction during development of cardiomyopathy was substantially reduced in the K.O. mice. Based on our prior studies emphasizing the adverse effects of plasma C5a and histones in the cardiomyopathy of sepsis, in TLR3- and TLR9-K.O. mice, there were striking reductions in plasma levels of C5a and histones as well as reduced levels of cytokines in plasma and heart tissue after CLP. Since we know that histones cause cardiac dysfunction, rat cardiomyocytes (CMs) were exposed in vitro to the histones (purified from calf thymus), which caused bleb formation on the surfaces of CMs, suggesting histones may perturb the cell membrane of CMs. In vitro, exposure of CMs to the histones for 3 hours caused lactate dehydrogenase release from CMs. These data indicate that sepsis-induced cardiac dysfunction requires presence of TLR3 and TLR9 and may be linked to histone-induced damage of CMs.

1. Introduction

The history of toll-like receptors (TLRs) began with the seminal discovery in 1981 that antimicrobial peptides represent a key mechanism of innate host defense in insects [1, 2]. TLRs, a family of pattern recognition receptors, are a critical component of the innate immune system and responsible for the host defense against foreign pathogens via pathogen‐associated molecular pattern (PAMP) recognition [3, 4]. Exposure of immune cells to the ligands of these receptors activates intracellular signaling cascades that rapidly induce the expression of a variety of overlapping and genes involved in the inflammatory and immune responses [3]. Recent studies indicate that certain TLRs can also function as the sensors for endogenously produced ligands with danger‐associated molecular pattern (DAMP). DAMP ligands are often produced upon tissue stresses such as ischemia, hypoxia, or trauma [5, 6]. The heart retains an innate immune system that is intended to delimit tissue injury, as well as orchestrate homoeostatic responses, within the heart related to host defenses and to healing responses, especially after hypoxia. Several studies suggest that this intrinsic stress response system is mediated, at least in part, by the TLRs [5, 6]. Most TLRs are expressed on cell surfaces and recognize mainly microbial membrane components such as lipids, lipoproteins and proteins; another TLR group such as TLR3 and TLR9 are expressed exclusively in intracellular vesicles such as the endoplasmic reticulum, endosomes, lysosomes and endolysosomes, where they recognize nucleic acids related to damaged cells or to microbe presence. TLR3 was originally identified as the receptor for double‐stranded RNA, polyinosinic-polycytidylic acid (polyI:C), which mimics viral infection and induces antiviral immune responses. TLR9 recognizes DNA derived from both DNA viruses and bacteria [7].

It is known that TLR3 and TLR9 are expressed both in vivo in the mouse heart as well as in vitro by cardiomyocytes (CMs) [8]. The role of TLR3 and TLR9 were shown in different conditions/diseases leading to cardiac dysfunction and which was associated with protection against cardiac dysfunction in the absence of either TLR3 [9, 10] or TLR9 [11, 12]. Injurious responses in mouse hearts infected with the coxsackievirus are also TLR9-dependent [13].

The harmful effects of TLR3 or TLR9 on cardiac dysfunction during sepsis have been reported [10, 12]. TLR3-/- mice showed preserved cardiac function after sepsis [10]. Also TLR9-/- mice showed attenuated septic cardiomyopathy and a significant reduction of cardiac inflammation after sepsis [12]. Besides the inflammatory cytokines, new biomarkers, “extracellular histones” were recently shown by our group and others to play a major role in sepsis-related multiorgan dysfunction and death [1417]. Histones are highly proinflammatory and prothrombotic [18]. We showed that extracellular histones are mainly released from neutrophils during sepsis after formation of neutrophil extracellular traps (NETs) which is C5a-dependent [14, 19, 20]. We have also shown that systemic histones neutralization mAb greatly attenuated the adverse effects of sepsis protecting the heart, resulting in enhanced survival after sepsis induced by cecal ligation and puncture (CLP) [14].

The complement system is also a critical component of the innate immune system and responsible for the host defense against foreign pathogens (bacteria, viruses, and fungi) [21, 22]. For several years, we have had a focus on dysfunction of the heart in sepsis and shown that such outcomes are linked to C5a and C5a receptors [14, 2327]. Complement system like TLRs system can be activated rapidly to provide crucial first-line host defense and act as mediators between innate and adaptive immunity [28]. Previous studies have demonstrated that TLR3 and TLR9 mediate a systemic inflammatory response and contribute to cardiac dysfunction in animal models of polymicrobial sepsis [10, 12], but the downstream mechanisms causing these injuries are unknown. TLRs and complement were commonly studied as separate components in the host defense [29]; the crosstalk between these two components during polymicrobial sepsis and their possible interplay in sepsis-induced cardiac dysfunction is poorly understood [30]. There is one study showing activation of TLR2, TLR3, and TLR4 remarkably enhanced complement factor B synthesis and release by CMs in vitro [30]. We decided to study the role of TLR3 and TLR9 in the heart function during polymicrobial sepsis and proposed the role for complement C5a and histones mediating these events. For this aim we performed heart functional studies in TLR3-/- and TLR9-/-, by applying Echo-Doppler technology after sepsis, to compare their responses with the septic Wt mice. We then measured the levels of proinflammatory cytokines (IL-6 and TNF), histones, and C5a in plasma from TLR3-/-, TLR9-/-, and Wt after inducing polymicrobial sepsis by CLP. We have also investigated the proinflammatory cytokines pattern in the heart tissue in these mice after inducing CLP.

2. Material and Methods

2.1. Animals and Anesthesia

Male C57BL/6 (Wt and TLR3-/-) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). Male BALB/c (Wt and TLR9-/-) mice were a donation from Theodore J. Standiford’s lab, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center. Mice (8 to 12 weeks old, 25–30g) were housed 5 per cage under conditions that were specific pathogen-free. Male pathogen-free Sprague-Dawley rats (250–300 g) were purchased from Harlan Laboratories (Indianapolis, IN). Animals were provided with a standard food diet and water. All animals were maintained according to protocols approved by University of Michigan Committee on the Use and Care of Animals and in accordance with the National Institutes of Health institutional guidelines. All animals were anesthetized using the combination of ketamine (Hospira, Lake Forest, IL) and xylazine (Lloyd Laboratories, Shenandoah, IA) intraperitoneally. Minimum five mice were used in each experiment.

2.2. Experimental Sepsis

Cecal ligation and puncture (CLP) procedure was used for inducing sepsis in mice as described previously [31]. For this study mid-grade CLP was used, which results in ~50% survival over 7 days. Sham animals underwent the same procedure, including manipulation of the bowel in the absence of CLP. All animals (control sham and CLP) received fluid resuscitation (1 ml saline, given subcutaneously in the nuchal region). The animals were euthanized at 8 hours (hr.) after CLP.

2.3. Blood and Heart Collection

At 8 hr. after the induction of CLP, anticoagulated blood (using acid citrate dextrose; ACD) was taken by cardiac puncture for collecting plasma. Then the hearts were excised, rinsed in ice-cold PBS, and was mechanically homogenized in RIPA lysis buffer (Millipore Sigma, Burlington, MA) containing protease inhibitor cocktail (Roche Diagnostics GmbH, Mannheim, Germany). Supernatants containing cytosolic protein were collected after centrifugation and used to detect the intracardiac cytokines. Myocardial cytokine levels were normalized to the protein concentration. Total protein estimations were determined by the bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO) according to the manufacturer's protocol.

2.4. Isolation of CMs

The isolation of adult rat CMs was performed using a Langendorff perfusion system, as we previously described [14, 25, 26]. The hearts were retrograde perfused with enzyme solution, according to manufacturer’s directions (Liberase; Hoffmann-La Roche, Mannheim, Germany). Following digestion, the heart was detached from the Langendorff apparatus, atria and vessels were removed, and the ventricles were cut into small pieces, which were gently triturated with a plastic transfer pipette. After isolation of the CMs, the Ca2+concentration in the buffer fluid was gradually increased (to 1.8 mM), and the cells were cultured in M199 medium with 1% insulin-transferrin-selenium-X (Gibco; Life Technologies, Carlsbad, CA) and antibiotic-antimycotic (Invitrogen, Carlsbad, CA).

2.5. Enzyme-Linked Immunosorbent Assays (ELISAs)

The levels of the TNF and IL-6 cytokines and complement C5a were measured in plasma taken from the Wt, TLR3-/-, and TLR9-/- mice by ELISA using DuoSet sandwich ELISA kits (R&D Systems, Minneapolis, MN). Cytokines levels were also measured in supernatants from heart homogenates from Wt, TLR3-/-, and TLR9-/- mice using DuoSet sandwich ELISA kits, according to the manufacturer's protocol. The levels of cytokines in the heart tissue were expressed as pg/mg heart tissue.

2.6. Histone ELISA

Histones levels in mouse plasma were measured by using a cell death detection ELISA kit (Sigma-Aldrich, St. Louis, MO) which detects all individual histones. A histone mixture (containing all individual histones of H1, H2A, H2B, H3, and H4) was used to establish a standard curve, as we described previously [14, 32].

2.7. Lactate Dehydrogenase (LDH) Cytotoxicity Assay

LDH assay was used to detect the cytotoxicity levels of histones on rat CMs according to the protocol which we described before [33]. Briefly, supernatants fluids were obtained from CMs exposed to histone, using phenol red-free media (Gibco, Grand Island, NY). The percentage of cytotoxicity (LDH release) from the sample treated with histone was measured compared to LDH content in total lysis fluids induced by 0.1% triton detergent (Sigma-Aldrich, St. Louis, MO). LDH release was measured using LDH assay kit (Cayman Chemical, Ann Arbor, MI) according to the manufacturer’s instructions.

2.8. Reagents

The following reagent/kit was used: purified histones from calf thymus and chemicals used for preparation of solutions for CM isolation were purchased from Sigma-Aldrich (St. Louis, MO). Endotoxin contamination of the histone preparations was <0.02 EU/mg using LAL assay (Lonza, Allendale, NJ) [33].

2.9. Confocal Imaging

For confocal imaging, CMs were cultured on sterile glass coverslips precoated with Poly-L-Y-Lysine (Sigma-Aldrich, St. Louis, MO). Cells were incubated with CellMask Deep Red Plasma membrane Stain (Invitrogen, Carlsbad, CA) after 30-minute treatment with the agonist. Confocal imaging was performed with a Zeiss LSM 510 Confocal microscope (Zeiss USA, Pleasanton, CA).

2.10. Transthoracic Echocardiography in Mice

Echocardiograms (Echos) were performed as previously described [14, 25, 26]. Briefly, all Echos were performed by a registered echocardiographer who was blinded to experiment details. Mice were weighed and anesthetized with inhaled isoflurane. Imaging was performed according to the recommendations of the American Society of Echocardiography using a Vevo 770 Micro-imaging system (Visualsonics Inc.) equipped with an RMV707B (15-45 MHz) transducer. Left ventricular (LV) area and LV length was measured from the parasternal long axis view and used to calculate the LV end systolic and diastolic volumes as follows: V = 4/3 x LV Area x LV length. The volumes at end systole (VolS) and end diastole (VolD) were used to calculate stroke volume (SV = VolD – VolS) and ejection fraction (EF% = SV / VolD x 100). Cardiac output (CO = SV x heart rate) was calculated from stroke volume and heart rate. Mitral valve E and A wave inflow velocities were sampled at the tips of the leaflets of the mitral valve from the apical four chamber view. Doppler tissue imaging was performed with acquisition of peak E’ velocity from the lateral (E’la) and septal annulus (E’sa) of the mitral valve imaged from the apical four chamber view. Isovolumic relaxation time, from the closure of the aortic valve to the opening of the mitral valve, was measured from the apical five chamber view using Doppler flow imaging. Imaging was performed at 8 hr. after CLP.

2.11. Statistical Analysis

All values were expressed as means ± SEM. Data were analyzed and graphed using GraphPad Prism software (GraphPad version 7, La Jolla, CA). Significant differences between two independent groups were determined, using independent student’s T test and between more than 2 groups using one-way ANOVA followed by Dunnett’s or Tukey’s multiple comparison test. Differences were considered significant when p< 0.05.

3. Results

3.1. Echo-Doppler Parameters in Septic Mice (Wt, TLR3-/-, TLR9-/-)(Figures 1 and 2)

To examine the contribution of the toll-like receptors, TLR3 and TLR9, to the in vivo functional changes in cardiovascular performance developing after CLP, Echo-Doppler was obtained 8 hr. after CLP in TLR3-/- (Figure 1), in TLR9-/- (Figure 2) mice and in control Wt littermate mice. As has been noted previously [14, 25, 26], mice subjected to CLP demonstrated significant abnormalities of systolic (frames (a)-(d) in Figures 1 and 2) and diastolic (frames (e)-(h) in both figures). There were important hemodynamic differences applied by Echo-Doppler technology related to TLR3-/- and TLR9-/- mice after CLP, suggesting that both receptors have important but different contributions to cardiac performance in response to sepsis. In response to CLP, both TLR3-/- and control Wt mice demonstrated significant decreases in stroke volume and cardiac output and a significant increase in ejection fraction (frames (a)-(h)). A modest reduction in heart rate developing in control Wt was not seen in TLR3-/- septic mice, but all other systolic measures were very similar. However, there were some subtle differences in measures of diastolic performance between in the TLR3-/- and control Wt. While control Wt animals demonstrated a significant increase in isovolemic relaxation time and significant increases in tissue relation velocities (E’la and E’sa) and LV end diastolic volume, TLR3-/- mice demonstrated similar trends in diastolic performance after CLP but only the increase in LV end diastolic volume reached statistical significance.

Unlike the TLR3-/- mice, TLR9-/- (Figure 2) mice demonstrated only modest hemodynamic changes in responses to CLP. Most measures of systolic and diastolic performance in TLR9-/- mice were equivalent to those in nonseptic mice. The only notable hemodynamic changes in the TLR9-/- mice after CLP was an increase in the LV ejection fraction and trend towards reduced LV end diastolic volumes. These suggest an important role for TLR9 in mediating the hemodynamic effects of CLP. While TLR3 receptor may participate in responses, our studies would suggest that their contribution is more modest while absence of TLR9 prevents most of the Echo-Doppler abnormalities developing after CLP when compared to responses of Wt mice.

3.2. Plasma Levels of C5a and Histones in Wt, TLR3-/-, and TLR9-/- 8 hr. after CLP (Figure 3)

In Figure 3, we determined plasma levels of C5a and histones (by ELISA) 8 hr. after CLP in Wt, TLR3-/-, and TLR9-/- mice, using the 8 hr. time period point which we know correlates with the cardiomyopathy of sepsis based on Echo-Doppler endpoints [14, 25, 26]. For each bar in Figure 3, number of the mice is ≥ 5 mice. As shown in frame (a), these were dramatic reductions in levels of plasma C5a when compared to levels in Wt mice (77% reduction in TLR3-/- mice [frame (a)] and 87% reduction in TLR9-/- mice [frame (b)]). It appears that C5a responses of septic mice were dramatically reduced in mice lacking TLR3 or TLR9. Reasons for these reductions are not known, since there is no definitive evidence on how sepsis causes complement activation resulting in C5a generation.

In frames (c) and (d), plasma histones were measured (by ELISA) in plasma 8 hr. after CLP, in Wt, TLR3-/-, and TLR9-/- mice. We have recently shown that plasma histones play an important role in the adverse events of sepsis including cardiomyopathy [14]. In these studies, plasma histones in TLR3-/- mice were reduced by 54% when compared to Wt mice and by 69% in TLR9-/- mice. Our recent data suggest that sepsis-induced generation of C5a which reacts with neutrophils containing C5a receptors, results in PMN activation, formation of NETs, and release of extracellular histones [14, 19, 20].

3.3. Effects of TLR3 or TLR9 Absence on Plasma Cytokines in Septic Mice (Figure 4)

We extended the studies to determine how absence of TLR3 (frames (a) and (b)) or TLR9 (frames (c) and (d)) in CLP mice affects sepsis-induced appearance of plasma proinflammatory cytokines. The data in Figure 4 show that plasma levels of IL-6 fell by 40% in TLR3-/- septic mice (frame (a)) and 52% in TLR9-/- septic mice (frame (c)) and absence of TLR3 or TLR9 resulted in reductions of plasma TNF by 50% (frame (b)) and 84% (frame (d)) respectively, compared to their Wt septic mice. While these data are preliminary, they indicate that TLR absence reduces plasma levels of proinflammatory cytokines, suggesting that events that “drive” the adverse consequences of sepsis are negatively affected by absence of TLR3 or TLR9.

3.4. Effects of TLR3 or TLR9 Absence on Heart Cytokines Content in Septic Mice (Figure 5)

We measured the levels of proinflammatory cytokines in cardiac tissue using heart homogenate to study how the absence of TLR3 or TLR9 affects the appearance of proinflammatory cytokines in the heart tissue after sepsis. As shown in Figure 5, the levels of the proinflammatory cytokines in TLR3-/- mice are significantly lower compared with the Wt at 8 hr. after inducing sepsis by more than 40% (42% in IL-6, 48% in TNF, and 43% in IL-1β levels) (frames (a)-(c)). In the case of TLR9-/-, the levels of proinflammatory cytokines in the heart tissue were remarkably lower compared to the Wt mice (55% in IL-6, 80% in TNF, and 50% in IL-1β levels) (frames (d)-(f)).

3.5. Evidence that Histones Cause Defects in CMs Exposed In Vitro to the Histones (Figure 6)

Since we know that circulating histones in septic mice are associated with CM dysfunction [14], two in vitro studies were completed. In Figure 6, CMs were isolated from normal rat hearts using established techniques described previously [14, 2527] and then incubated for 3 hr. at 37°C with buffer (vehicle control) or with the histones (50 μg/ml). This concentration approaches levels of plasma histones levels in septic Wt mice [14]. As is apparent in Figure 6, CMs incubated in buffer for 3 hr. at 37°C released some LDH, which approached 20% of total LDH in CMs. However, in the presence of the histones, almost 50% of the total LDH in CMs was released, indicating that the histones cause damage to CMs. The reason for LDH release from buffer-exposed CMs is probably due to the isolation and culture process. The process of isolating adult CMs carries an inherent risk of causing cellular damage, activation of stress response pathways [34], which can lead to reducing cell viability. In fact, the CMs isolation technique requires a long procedure and needs digestive enzymes to free up the CMs and reintroducing them into a calcium-containing medium after isolation. For LDH assay experiment, we had to incubate these CMs with buffer or histones for 3 hr. which all may result in releasing LDH.

We have also found the morphological evidence of damage to CMs after exposure to the histones. Based on the LDH data in in the left panel in which exposure of CMs to the histones caused LDH release, in the right panel, we studied the morphological changes in the rat CMs after incubating with the histones (50 μg/ml), for 30 minutes at 37°C. We then exposed the CMs to CellMask Deep Red Plasma membrane stain for 10 minutes at 37°C and washed and examined by light microscopy for morphological changes, with a focus on the cell membrane. The CellMask™ Plasma Membrane Stains allow fast and uniform labeling of the plasma membrane without the cell-type differences exhibited by lectins and is a lipophilic fluorophore which is an excellent live and fixed cell membrane stain for cellular plasma membranes [3538]. The red stain has been used to detect changes in the basement membrane of various cell types, especially the presence of blebs in the cell membrane. The CMs exposed to buffer (vehicle control) showed smooth cell membranes with no evidence of bleb formation (frames 1a, 1b in the right panel). In striking contrast, CMs exposed to the histones showed diffuse numerous blebs on the cell membranes (frames 2a, 2b in the right panel). There was some evidence in CMs exposed to the histones that blebs associated with the cell membrane were being released. We believe these data show the ability of the histones to induce significant bleb formation in CM cell membranes, with occasional release of blebs, indicating adverse changes in the CM cell membranes as a result of exposure to the histones. Such events appear to correlate with release of LDH shown in the left panel. It is not known if C5a induce similar changes in CM cell membranes.

4. Discussion

In the setting of polymicrobial sepsis, most studies in the past investigated the role of TLR2 and TLR4 as mediating a systemic inflammatory response. In general these studies have shown that TLR2 and TLR4 contribute to high mortality and multiorgan dysfunction in animal models of polymicrobial sepsis [3942]. There is also limited evidence suggesting protective effects and decreased mortality in mice that lack either of the TLR3 or TLR9 receptor after CLP [10, 43, 44]. Our functional data measuring Echo-Doppler parameters (Figures 1 and 2) show in the absence of either TLR3 or TLR9 the intensity of cardiac dysfunction during development of septic cardiomyopathy was substantially reduced in K.O. mice, especially in TLR9-/- mice. These data suggest that TLR9 and, with more modest effect, TLR3 involvement play important roles in mediating the hemodynamic effects of CLP. Our data are in line with the published reports in which TLR3-/- mice showed significant attenuation of cardiac dysfunction or myocardial necrosis after myocardial infarction or during ischemia-reperfusion injury [45, 46]. TLR3-/- mice are shown to have more survival after inducing polymicrobial sepsis and showed a maintenance of cardiac function at pre-CLP levels [10]. Decreased CLP-induced cardiac myocyte apoptosis and attenuated CLP-induced Fas and FasL expression in the myocardium of TLR3-/- mice were proposed as the underlying mechanism by the investigators [10]. TLR9 also appeared to play a role in myocardial inflammation as well as defective cardiac contractility [47]. TLR9-/- mice showed increased survival after CLP compared to the Wt which was associated with enhanced clearance of bacteria from the blood and peritoneal cavity, as well as a dramatic decrease in serum inflammatory cytokines [44]. In line with the mentioned findings from TLR3-/- and TLR9-/- mice, our data in Figures 35 show remarkably less intensified inflammatory pattern, extracellular histone released, and C5a production in these K.O. mice compared to the Wt mice during sepsis.

It has been reported that signaling pathways upon stimulation of TLRs (including TLR3 and TLR9) in variety of cell types (e.g., lymphocytes, macrophages, and dendritic cells) result in activation of a series of signaling proteins in which expression of proinflammatory cytokine and chemokine genes is increased [48]. Our data showing lower levels of proinflammatory cytokines in the K.O. mice suggest that signaling through TLR3 and TLR9 involves release of these proinflammatory cytokines during sepsis. Moreover, the lower levels of complement C5a and extracellular histones in plasma during sepsis in TLR3-/- and TLR9-/- mice suggest that these biological markers may act as a downstream effector of TLR3 and TLR9 signaling. This is an important finding since complement activation product, C5a, is a part of the innate immune system components although C5a protects the host against infectious organisms as well as noninfectious agents via innate immune pathways [29], but excessive production of C5a during sepsis results in a series of harmful consequences [49]. Extracellular histones may also cause a series of responses that are tissue damaging or prothrombotic during sepsis [14, 15, 18], as also shown here damage in CMs after exposure to histones (Figure 6). In the past we have shown protective effects of the histone antibody (clone BWA3) against hearts dysfunction during polymicrobial sepsis. Cardiac function parameters in septic mice were improved with using this antibody, as measured by Echo-Doppler [14]. Although it is still unknown about the interplay between extracellular histones and TLR3 but it has been shown that extracellular histones function as DAMPs through TLR9 after ischemic injury to initiate inflammation [50, 51]. Our data indicate that both TLR3 and TLR9 contribute to systemic inflammatory responses and multiorgan dysfunction in which the production of extracellular histones and C5a are increased mediating septic cardiomyopathy in mice following CLP.

Data Availability

All data generated or analysed during this study are included within the article. Our prior studies to support some of our data (Echo-Doppler data) are cited at relevant places within the text as references [14, 2527].

Conflicts of Interest

The authors declare there are no commercial or financial conflicts of interest related to this study.

Acknowledgments

The authors acknowledge support from the Microscopy and Image Analysis Laboratory (MIL), University of Michigan (UM) Medical School, a multiuser imaging facility supported by a grant from the U.S. National Institutes of Health (NIH) National Cancer Institute, the O’Brien Renal Center, the UM Medical School, the Endowment for the Basic Sciences (EBS), and the UM Department of Cell and Developmental Biology. They thank Kimber Converso-Baran, research sonographer and echocardiographic specialist, for excellent services provided. This study was supported by the National Institutes of Health (NIH), General Medicine Grants GM-29507 and GM-61656 (to Peter A. Ward), as well as funds provided by the Department of Pathology, University of Michigan Medical School.

References

  1. H. Steiner, D. Hultmark, A. Engstrom, H. Bennich, and H. G. Boman, “Sequence and specificity of two antibacterial proteins involved in insect immunity,” Nature, vol. 292, no. 5820, pp. 246–248, 1981. View at: Publisher Site | Google Scholar
  2. J. L. Strominger, “Animal Antimicrobial Peptides: Ancient Players in Innate Immunity,” The Journal of Immunology, vol. 182, no. 11, pp. 6633-6634, 2009. View at: Publisher Site | Google Scholar
  3. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at: Publisher Site | Google Scholar
  4. R. Medzhitov and C. Janeway Jr., “The Toll receptor family and microbial recognition,” Trends in Microbiology, vol. 8, no. 10, pp. 452–456, 2000. View at: Publisher Site | Google Scholar
  5. D. L. Mann, “The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls,” Circulation Research, vol. 108, no. 9, pp. 1133–1145, 2011. View at: Publisher Site | Google Scholar
  6. W. Chao, “Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 1, pp. H1–H12, 2009. View at: Publisher Site | Google Scholar
  7. T. Kawai and S. Akira, “The role of pattern-recognition receptors in innate immunity: update on toll-like receptors,” Nature Immunology, vol. 11, no. 5, pp. 373–384, 2010. View at: Publisher Site | Google Scholar
  8. J. H. Boyd, S. Mathur, Y. Wang, R. M. Bateman, and K. R. Walley, “Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-κB dependent inflammatory response,” Cardiovascular Research, vol. 72, no. 3, pp. 384–393, 2006. View at: Publisher Site | Google Scholar
  9. H. S. Hardarson, J. S. Baker, Z. Yang et al., “Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 1, pp. H251–H258, 2007. View at: Publisher Site | Google Scholar
  10. M. Gao, T. Ha, X. Zhang et al., “Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis,” Critical Care Medicine, vol. 40, no. 8, pp. 2390–2399, 2012. View at: Publisher Site | Google Scholar
  11. O. Boehm, P. Markowski, M. van der Giet et al., “In Vivo TLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction,” Mediators of Inflammation, vol. 2013, Article ID 217297, 9 pages, 2013. View at: Publisher Site | Google Scholar
  12. R. Lohner, M. Schwederski, C. Narath, J. Klein, G. D. Duerr et al., “Toll-Like Receptor 9 Promotes Cardiac Inflammation and Heart Failure during Polymicrobial Sepsis,” Mediators of Inflammation, vol. 2013, Article ID 261049, 13 pages, 2013. View at: Publisher Site | Google Scholar
  13. A. Riad, D. Westermann, F. Escher et al., “Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 6, pp. H2024–H2031, 2010. View at: Publisher Site | Google Scholar
  14. M. Kalbitz, J. J. Grailer, F. Fattahi et al., “Role of extracellular histones in the cardiomyopathy of sepsis,” The FASEB Journal, vol. 29, no. 5, pp. 2185–2193, 2015. View at: Publisher Site | Google Scholar
  15. J. Xu, X. Zhang, R. Pelayo et al., “Extracellular histones are major mediators of death in sepsis,” Nature Medicine, vol. 15, no. 11, pp. 1318–1321, 2009. View at: Publisher Site | Google Scholar
  16. F. Wang, N. Zhang, B. Li, L. Liu, L. Ding, Y. Wang et al., “Heparin defends against the toxicity of circulating histones in sepsis,” Frontiers in Bioscience, vol. 20, pp. 1259–1270, 2015. View at: Google Scholar
  17. M. L. Ekaney, G. P. Otto, M. Sossdorf et al., “Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation,” Critical Care, vol. 18, no. 5, article 543, 2014. View at: Publisher Site | Google Scholar
  18. T. A. Fuchs, A. Brill, D. Duerschmied et al., “Extracellular DNA traps promote thrombosis,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 107, no. 36, pp. 15880–15885, 2010. View at: Publisher Site | Google Scholar
  19. F. Fattahi, J. J. Grailer, L. Jajou, F. S. Zetoune, A. V. Andjelkovic, and P. A. Ward, “Organ distribution of histones after intravenous infusion of FITC histones or after sepsis,” Immunologic Research, vol. 61, no. 3, pp. 177–186, 2015. View at: Publisher Site | Google Scholar
  20. J. J. Grailer, F. Fattahi, R. S. Dick, F. S. Zetoune, and P. A. Ward, “Cutting edge: critical role for C5aRs in the development of septic lymphopenia in mice,” The Journal of Immunology, vol. 194, no. 3, pp. 868–872, 2015. View at: Publisher Site | Google Scholar
  21. R. Medzhitov, “Recognition of microorganisms and activation of the immune response,” Nature, vol. 449, no. 7164, pp. 819–826, 2007. View at: Publisher Site | Google Scholar
  22. M. M. Markiewski and J. D. Lambris, “The role of complement in inflammatory diseases from behind the scenes into the spotlight,” The American Journal of Pathology, vol. 171, no. 3, pp. 715–727, 2007. View at: Publisher Site | Google Scholar
  23. A. D. Niederbichler, L. M. Hoesel, M. V. Westfall et al., “An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction,” The Journal of Experimental Medicine, vol. 203, no. 1, pp. 53–61, 2006. View at: Publisher Site | Google Scholar
  24. G. Atefi, F. S. Zetoune, T. J. Herron et al., “Complement dependency of cardiomyocyte release of mediators during sepsis,” The FASEB Journal, vol. 25, no. 7, pp. 2500–2508, 2011. View at: Publisher Site | Google Scholar
  25. M. Kalbitz, F. Fattahi, T. J. Herron et al., “Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro,” The Journal of Immunology, vol. 197, no. 6, pp. 2353–2361, 2016. View at: Publisher Site | Google Scholar
  26. M. Kalbitz, F. Fattahi, J. J. Grailer et al., “Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis,” The FASEB Journal, vol. 30, no. 12, pp. 3997–4006, 2016. View at: Publisher Site | Google Scholar
  27. F. Fattahi, M. Kalbitz, E. A. Malan et al., “Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction,” The FASEB Journal, vol. 31, no. 9, pp. 4129–4139, 2017. View at: Publisher Site | Google Scholar
  28. G. Hajishengallis and J. D. Lambris, “Crosstalk pathways between Toll-like receptors and the complement system,” Trends in Immunology, vol. 31, no. 4, pp. 154–163, 2010. View at: Publisher Site | Google Scholar
  29. D. Ricklin, G. Hajishengallis, K. Yang, and J. D. Lambris, “Complement: a key system for immune surveillance and homeostasis,” Nature Immunology, vol. 11, no. 9, pp. 785–797, 2010. View at: Publisher Site | Google Scholar
  30. L. Zou, Y. Feng, Y. Li et al., “Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis,” The Journal of Immunology, vol. 191, no. 11, pp. 5625–5635, 2013. View at: Publisher Site | Google Scholar
  31. D. Rittirsch, M. S. Huber-Lang, M. A. Flierl, and P. A. Ward, “Immunodesign of experimental sepsis by cecal ligation and puncture,” Nature Protocols, vol. 4, no. 1, pp. 31–36, 2009. View at: Publisher Site | Google Scholar
  32. M. Bosmann, J. J. Grailer, R. Ruemmler et al., “Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury,” The FASEB Journal, vol. 27, no. 12, pp. 5010–5021, 2013. View at: Publisher Site | Google Scholar
  33. F. Fattahi, J. J. Grailer, H. Lu et al., “Selective Biological Responses of Phagocytes and Lungs to Purified Histones,” Journal of Innate Immunity, vol. 9, no. 3, pp. 300–317, 2017. View at: Publisher Site | Google Scholar
  34. M. Ackers-Johnson, P. Y. Li, A. P. Holmes, S.-M. O'Brien, D. Pavlovic, and R. S. Foo, “A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes from the Adult Mouse Heart,” Circulation Research, vol. 119, no. 8, pp. 909–920, 2016. View at: Publisher Site | Google Scholar
  35. V. Mönkemöller, M. Schüttpelz, P. McCourt, K. Sørensen, B. Smedsrød, and T. Huser, “Imaging fenestrations in liver sinusoidal endothelial cells by optical localization microscopy,” Phys. Chem. Chem. Phys., vol. 16, no. 24, pp. 12576–12581, 2014. View at: Publisher Site | Google Scholar
  36. A. Cardone, F. Lopez, F. Affortunato et al., “An aryleneethynylene fluorophore for cell membrane staining,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1818, no. 11, pp. 2808–2817, 2012. View at: Publisher Site | Google Scholar
  37. R. S. Leow, J. M. Wan, and A. C. Yu, “Membrane blebbing as a recovery manoeuvre in site-specific sonoporation mediated by targeted microbubbles,” Journal of the Royal Society Interface, vol. 12, no. 105, pp. 20150029–20150029, 2015. View at: Publisher Site | Google Scholar
  38. H. R. Jia, H. Y. Wang, Z. W. Yu, Z. Chen, and F. G. Wu, “Long-Time Plasma Membrane Imaging Based on a Two-Step Synergistic Cell Surface Modification Strategy,” Bioconjugate Chemistry, vol. 27, no. 3, pp. 782–789, 2016. View at: Publisher Site | Google Scholar
  39. J. C. Alves-Filho, A. Freitas, F. O. Souto, F. Spiller, H. Paula-Neto, J. S. Silva et al., “Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis,” PNAS: Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 10, pp. 4018–4023, 2009. View at: Google Scholar
  40. L. Zou, Y. Feng, Y. J. Chen et al., “Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis,” Critical Care Medicine, vol. 38, no. 5, pp. 1335–1342, 2010. View at: Publisher Site | Google Scholar
  41. J. C. Alves-Filho, A. De Freitas, M. Russo, and F. Q. Cunha, “Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis,” Critical Care Medicine, vol. 34, no. 2, pp. 461–470, 2006. View at: Publisher Site | Google Scholar
  42. T. Roger, C. Froidevaux, D. Le Roy et al., “Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 106, no. 7, pp. 2348–2352, 2009. View at: Publisher Site | Google Scholar
  43. K. A. Cavassani, M. Ishii, H. Wen et al., “TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events,” The Journal of Experimental Medicine, vol. 205, no. 11, pp. 2609–2621, 2008. View at: Publisher Site | Google Scholar
  44. G. Plitas, B. M. Burt, H. M. Nguyen, Z. M. Bamboat, and R. P. DeMatteo, “Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis,” The Journal of Experimental Medicine, vol. 205, no. 6, pp. 1277–1283, 2008. View at: Publisher Site | Google Scholar
  45. C. Chen, Y. Feng, L. Zou et al., “Role of Extracellular RNA and TLR3-Trif Signaling in Myocardial Ischemia-Reperfusion Injury,” Journal of the American Heart Association, vol. 3, no. 1, pp. e000683–e000683, 2014. View at: Publisher Site | Google Scholar
  46. C. Lu, D. Ren, X. Wang et al., “Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1842, no. 1, pp. 22–31, 2014. View at: Publisher Site | Google Scholar
  47. P. Knuefermann, M. Schwederski, M. Velten et al., “Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: Role of Toll-like receptor 9,” Cardiovascular Research, vol. 78, no. 1, pp. 26–35, 2008. View at: Publisher Site | Google Scholar
  48. S. Akira, K. Takeda, and T. Kaisho, “Toll-like receptors: critical proteins linking innate and acquired immunity,” Nature Immunology, vol. 2, no. 8, pp. 675–680, 2001. View at: Publisher Site | Google Scholar
  49. P. A. Ward, “The dark side of C5a in sepsis,” Nature Reviews Immunology, vol. 4, no. 2, pp. 133–142, 2004. View at: Publisher Site | Google Scholar
  50. H. Huang, H.-W. Chen, J. Evankovich et al., “Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury,” The Journal of Immunology, vol. 191, no. 5, pp. 2665–2679, 2013. View at: Publisher Site | Google Scholar
  51. H. Huang, J. Evankovich, W. Yan et al., “Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice,” Hepatology, vol. 54, no. 3, pp. 999–1008, 2011. View at: Publisher Site | Google Scholar

Copyright © 2018 Fatemeh Fattahi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

677 Views | 316 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.